ONCOLife Articles
Lung Organoids Offer a Revolutionary Path to Transform Drug Testing and Cancer Therapies
Biotech | 2 December 2025
Nanotherapy Reprograms Glioblastoma Immunity Through Nose-to-Brain Delivery
ONCOLife | 2 December 2025
Enozertinib Shows Strong Systemic and CNS Activity in EGFR Exon 20+ NSC Lung Cancer
Clinical Trials | 6 December 2025
Colibactin’s Molecular Blueprint Exposes How a Gut Microbial Toxin Triggers Colorectal Cancer
ONCOLife | 6 December 2025
Blood-Based cfDNA Test Demonstrates Potential for Detecting Lung Cancer in Nonsmokers
ONCOLife | 5 December 2025
FDA Approves Durvalumab as First Perioperative Immunotherapy for GEJ Cancers
FDA & EMA | 26 November 2025
FDA Approves Keytruda–Padcev Combo as First Perioperative Treatment for Bladder Cancer
FDA & EMA | 24 November 2025
Radioligand Therapy Pluvicto Reduces Progression Risk by 28% in mHS Prostate Cancer
ONCOLife | 5 November 2025
ctDNA Blood Test Guides Chemotherapy Decisions for Tailored Colon Cancer Treatment
ONCOLife
4 November 2025
Trodelvy Emerges as Potential New Standard for First-Line Metastatic TN Breast Cancer
ONCOLife
24 October 2025
ESMO’s Road Map for Safe and Effective Use of AI-LLMs in Cancer Care: 23 Rules from 20 Experts
AI
3 November 2025
Datroway Extends Survival by 5 Months in Metastatic Triple-Negative Breast Cancer
ONCOLife
21 October 2025
AI Analysis of Thymic Health Predicts Immunotherapy Success, Cutting Death Risk by 44%
ONCOLife
18 October 2025
Lenvatinib Plus Pembrolizumab Delivers Durable 5-Year Survival in Endometrial Carcinoma
ONCOLife
20 October 2025
Disarming Prostate Cancer: Dual Enzyme Blockade Weakens Tumors and Boosts Drug Response
ONCOLife
14 October 2025
Molecular Trojan Horse: Peptide Nanotubes Offer a Path to Defeat Drug-Resistant Tumors
ONCOLife
13 October 2025
Reprogramming Cancer Cell Death: A New Immune-Based Strategy for Blood Cancers
ONCOLife
12 October 2025
Datroway Improves Survival in First-Line Treatment of Metastatic Triple- Breast Cancer
ONCOLife
6 October 2025
Dr. Eleni Lagkadinou Discusses How AbbVie Is Advancing Targeted Innovation for HT Cancers
ONCOLife
1 October 2025
The VAPOR 2 Trial and the Potential of Water Vapor Ablation in Prostate Cancer Treatment
ONCOLife
2 October 2025
ONCOLife as a cutting-edge oncology magazine designed for oncologists and health professionals. It has flexible format, available both in print and online formats in the US and EU, ONCOLife is dedicated to covering key developments in the field of oncology. We delve into the stories behind significant clinical research and drug developments, highlight the latest news, and offer exclusive interviews.
